• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

移植肝再感染 HCV 和 HCV/HIV 感染患者的特征是不同的 microRNA 表达谱。

Reinfection of Transplanted Livers in HCV- and HCV/HIV-Infected Patients Is Characterized by a Different MicroRNA Expression Profile.

机构信息

Department of Medicine, University of Udine, 33100 Udine, Italy.

Institute of Pathology, University Hospital of Udine, 33100 Udine, Italy.

出版信息

Cells. 2022 Feb 16;11(4):690. doi: 10.3390/cells11040690.

DOI:10.3390/cells11040690
PMID:35203343
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8869900/
Abstract

BACKGROUND

After liver transplantation, HCV/HIV co-infected patients present, compared to the HCV mono-infected ones, increased HCV viral load, rapid progression to liver fibrosis and higher mortality. Liver biopsies (LB), obtained routinely 6 months after transplantation, represent a unique model to assess the early events related to graft re-infection. Here, we used miRNA sequencing of LB obtained from both HCV-and HCV/HIV-infected recipients, to identify transcriptional profiles able to explain the more severe outcome of these latter.

METHODS

miRNAs of 3 healthy livers, 3 HCV-LB and 3 HCV/HIV-LB were sequenced by Illumina HiSeq2500 platform. The DIANA-miRPath v3.0 webserver and DIANA-microT-CDS algorithm (v5.0) were used to characterize the functions of differentially expressed (DE-) miRNAs, querying the KEGG and Gene Ontology-Biological Process databases.

RESULTS

LB obtained from infected patients were characterized, with respect to controls, by a miRNA profile related to viral infection, immune system signaling and DNA damage in HCV-induced carcinogenesis. Instead, HCV-LB and HCV/HIV-LB differed in the expression of miRNAs involved in immunological and apoptotic processes and in extracellular matrix remodeling.

CONCLUSIONS

liver reinfection processes are associated with early miRNA changes. Further studies are necessary to establish their prognostic role and possible actionability.

摘要

背景

肝移植后,HCV/HIV 合并感染患者的 HCV 病毒载量增加,肝纤维化快速进展,死亡率较高,与 HCV 单感染患者相比。肝活检(LB)通常在移植后 6 个月获得,是评估与移植物再感染相关的早期事件的独特模型。在这里,我们使用来自 HCV 和 HCV/HIV 感染受者的 LB 的 miRNA 测序,来确定能够解释这些受者更严重结局的转录谱。

方法

通过 Illumina HiSeq2500 平台对 3 个健康肝脏、3 个 HCV-LB 和 3 个 HCV/HIV-LB 的 miRNAs 进行测序。使用 DIANA-miRPath v3.0 网络服务器和 DIANA-microT-CDS 算法(v5.0)来描述差异表达(DE-)miRNAs 的功能,查询 KEGG 和基因本体生物学过程数据库。

结果

与对照组相比,受感染患者的 LB 具有与病毒感染、免疫系统信号和 HCV 诱导的癌变中的 DNA 损伤相关的 miRNA 谱。相反,HCV-LB 和 HCV/HIV-LB 在参与免疫和凋亡过程以及细胞外基质重塑的 miRNA 表达上存在差异。

结论

肝再感染过程与早期 miRNA 变化有关。需要进一步研究来确定它们的预后作用和可能的可操作性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d9/8869900/dc4109c95d53/cells-11-00690-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d9/8869900/9981aacd2d6a/cells-11-00690-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d9/8869900/91a2b90308c7/cells-11-00690-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d9/8869900/f4271062dc1e/cells-11-00690-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d9/8869900/f29d79533112/cells-11-00690-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d9/8869900/8622518f78d1/cells-11-00690-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d9/8869900/478c223f9ea2/cells-11-00690-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d9/8869900/62b775158513/cells-11-00690-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d9/8869900/d694311ca0ff/cells-11-00690-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d9/8869900/dc4109c95d53/cells-11-00690-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d9/8869900/9981aacd2d6a/cells-11-00690-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d9/8869900/91a2b90308c7/cells-11-00690-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d9/8869900/f4271062dc1e/cells-11-00690-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d9/8869900/f29d79533112/cells-11-00690-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d9/8869900/8622518f78d1/cells-11-00690-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d9/8869900/478c223f9ea2/cells-11-00690-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d9/8869900/62b775158513/cells-11-00690-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d9/8869900/d694311ca0ff/cells-11-00690-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d9/8869900/dc4109c95d53/cells-11-00690-g009.jpg

相似文献

1
Reinfection of Transplanted Livers in HCV- and HCV/HIV-Infected Patients Is Characterized by a Different MicroRNA Expression Profile.移植肝再感染 HCV 和 HCV/HIV 感染患者的特征是不同的 microRNA 表达谱。
Cells. 2022 Feb 16;11(4):690. doi: 10.3390/cells11040690.
2
miRNA expression profiles in liver grafts of HCV and HIV/HCV-infected recipients, 6 months after liver transplantation.肝移植后 6 个月 HCV 和 HIV/HCV 感染受者肝移植物中的 miRNA 表达谱。
J Med Virol. 2021 Aug;93(8):4992-5000. doi: 10.1002/jmv.26999. Epub 2021 May 4.
3
MicroRNA signature from extracellular vesicles of HCV/HIV co-infected individuals differs from HCV mono-infected.来自 HCV/HIV 共感染个体细胞外囊泡的 microRNA 特征与 HCV 单感染不同。
J Mol Med (Berl). 2023 Nov;101(11):1409-1420. doi: 10.1007/s00109-023-02367-8. Epub 2023 Sep 14.
4
Intrahepatic MicroRNA Profile of Liver Transplant Recipients with Hepatitis C Virus Co-Infected with Human Immunodeficiency Virus.丙型肝炎病毒与人类免疫缺陷病毒合并感染的肝移植受者的肝内微小RNA图谱
Ann Transplant. 2017 Nov 24;22:701-706. doi: 10.12659/aot.906236.
5
The assessment of selected MiRNAs profile in HIV, HBV, HCV, HIV/HCV, HIV/HBV Co-infection and elite controllers for determination of biomarker.评估 HIV、HBV、HCV、HIV/HCV、HIV/HBV 合并感染和精英控制者中选定的 miRNA 谱,以确定生物标志物。
Microb Pathog. 2020 Oct;147:104355. doi: 10.1016/j.micpath.2020.104355. Epub 2020 Jun 20.
6
Genome-wide mRNA and miRNA analysis of peripheral blood mononuclear cells (PBMC) reveals different miRNAs regulating HIV/HCV co-infection.对外周血单核细胞(PBMC)的全基因组 mRNA 和 miRNA 分析显示,不同的 miRNA 可调控 HIV/HCV 合并感染。
Virology. 2014 Feb;450-451:336-49. doi: 10.1016/j.virol.2013.12.026. Epub 2014 Jan 14.
7
Distinct microRNA profiles are associated with the severity of hepatitis C virus recurrence and acute cellular rejection after liver transplantation.不同的 microRNA 谱与肝移植后丙型肝炎病毒复发和急性细胞排斥的严重程度相关。
Liver Transpl. 2013 Apr;19(4):383-94. doi: 10.1002/lt.23613. Epub 2013 Mar 22.
8
Kidney and liver organ transplantation in persons with human immunodeficiency virus: An Evidence-Based Analysis.人类免疫缺陷病毒感染者的肾脏和肝脏器官移植:一项基于证据的分析。
Ont Health Technol Assess Ser. 2010;10(4):1-56. Epub 2010 Mar 1.
9
Hepatitis viruses and liver transplantation.肝炎病毒与肝移植
J Gastroenterol Hepatol. 1997 Oct;12(9-10):S335-41. doi: 10.1111/j.1440-1746.1997.tb00518.x.
10
MicroRNAs, hepatitis C virus, and HCV/HIV-1 co-infection: new insights in pathogenesis and therapy.微小 RNA 、丙型肝炎病毒和丙型肝炎病毒/人类免疫缺陷病毒 1 合并感染:发病机制和治疗的新见解。
Viruses. 2012 Oct 26;4(11):2485-513. doi: 10.3390/v4112485.

引用本文的文献

1
Extracellular vesicles derived microRNAs as non-invasive markers of liver fibrosis in chronically infected HCV patients: a pilot study.慢性丙型肝炎病毒感染患者中,细胞外囊泡衍生的微小RNA作为肝纤维化的非侵入性标志物:一项初步研究。
Noncoding RNA Res. 2025 Mar 5;12:132-140. doi: 10.1016/j.ncrna.2025.03.004. eCollection 2025 Jun.
2
Urinary α 1-microglobulin and β 2-microglobulin as markers of early kidney injury in HIV-positive male patients on tenofovir-based antiretroviral therapy.基于替诺福韦的抗逆转录病毒治疗的 HIV 阳性男性患者中尿α 1-微球蛋白和β 2-微球蛋白作为早期肾损伤的标志物。
PLoS One. 2024 Jun 17;19(6):e0303442. doi: 10.1371/journal.pone.0303442. eCollection 2024.
3

本文引用的文献

1
HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients.直接作用抗病毒药物治愈 HCV 可改善 HIV/HCV 合并感染患者的肝脏和免疫标志物。
Front Immunol. 2021 Aug 23;12:723196. doi: 10.3389/fimmu.2021.723196. eCollection 2021.
2
A Tale of Two Viruses: Immunological Insights Into HCV/HIV Coinfection.两种病毒的故事:HCV/HIV 合并感染的免疫学见解。
Front Immunol. 2021 Aug 12;12:726419. doi: 10.3389/fimmu.2021.726419. eCollection 2021.
3
Neurological and psychiatric effects of hepatitis C virus infection.
Clinical outcomes of liver transplantation in human immunodeficiency virus/hepatitis B virus coinfected patients in China.
中国人类免疫缺陷病毒/乙型肝炎病毒合并感染患者肝移植的临床结果。
BMC Infect Dis. 2024 Apr 8;24(1):383. doi: 10.1186/s12879-024-09284-2.
4
MicroRNA signature from extracellular vesicles of HCV/HIV co-infected individuals differs from HCV mono-infected.来自 HCV/HIV 共感染个体细胞外囊泡的 microRNA 特征与 HCV 单感染不同。
J Mol Med (Berl). 2023 Nov;101(11):1409-1420. doi: 10.1007/s00109-023-02367-8. Epub 2023 Sep 14.
5
The involvement of microRNAs in HCV and HIV infection.微小RNA在丙型肝炎病毒和人类免疫缺陷病毒感染中的作用。
Ther Adv Vaccines Immunother. 2022 Jul 5;10:25151355221106104. doi: 10.1177/25151355221106104. eCollection 2022.
丙型肝炎病毒感染的神经和精神影响。
World J Gastroenterol. 2021 Aug 7;27(29):4846-4861. doi: 10.3748/wjg.v27.i29.4846.
4
Exosomes Derived From Heat Stroke Cases Carry miRNAs Associated With Inflammation and Coagulation Cascade.热射病患者来源的外泌体携带与炎症和凝血级联反应相关的 miRNA。
Front Immunol. 2021 Jun 22;12:624753. doi: 10.3389/fimmu.2021.624753. eCollection 2021.
5
"Raising HOPE": Improved Outcomes for HIV/HCV-coinfected Liver Transplant Recipients in the Direct-acting Antiviral Era.《孕育希望》:直接抗病毒药物时代HIV/HCV合并感染肝移植受者的预后改善
Transplant Direct. 2021 Jun 8;7(7):e707. doi: 10.1097/TXD.0000000000001154. eCollection 2021 Jul.
6
miRNA expression profiles in liver grafts of HCV and HIV/HCV-infected recipients, 6 months after liver transplantation.肝移植后 6 个月 HCV 和 HIV/HCV 感染受者肝移植物中的 miRNA 表达谱。
J Med Virol. 2021 Aug;93(8):4992-5000. doi: 10.1002/jmv.26999. Epub 2021 May 4.
7
Circulating microRNA signatures that predict liver fibrosis progression in patients with HIV-1/hepatitis C virus coinfections.循环 microRNA 特征可预测 HIV-1/丙型肝炎病毒合并感染患者的肝纤维化进展。
AIDS. 2021 Jul 15;35(9):1355-1363. doi: 10.1097/QAD.0000000000002895.
8
Emerging roles and mechanisms of microRNA‑222‑3p in human cancer (Review).微小 RNA-222-3p 在人类癌症中的新兴作用和机制(综述)。
Int J Oncol. 2021 May;58(5). doi: 10.3892/ijo.2021.5200. Epub 2021 Mar 24.
9
Successful HCV Therapy Reduces Liver Disease Severity and Inflammation Biomarkers in HIV/HCV-Coinfected Patients With Advanced Cirrhosis: A Cohort Study.成功的丙型肝炎病毒治疗可降低晚期肝硬化的HIV/丙型肝炎病毒合并感染患者的肝病严重程度和炎症生物标志物:一项队列研究。
Front Med (Lausanne). 2021 Feb 1;8:615342. doi: 10.3389/fmed.2021.615342. eCollection 2021.
10
microRNA-125a targets MAVS and TRAF6 to modulate interferon signaling and promote HCV infection.microRNA-125a 靶向 MAVS 和 TRAF6 调节干扰素信号并促进 HCV 感染。
Virus Res. 2021 Apr 15;296:198336. doi: 10.1016/j.virusres.2021.198336. Epub 2021 Feb 9.